YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Ra Pharmaceuticals Launches Protein-Like Drugs


May 24, 2012 | Ra Pharmaceuticals is announcing a $8.6 million tranche closing of a $27 million Series A round. The Cambridge, Mass.-based company has a technology platform to develop protein-like molecules that it calls Cyclomimetrics. The technology was licensed from Uppsala University in Sweden, and makes large molecules that can be made into pills. Xconomy
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.